PASG 8-K: Delisting notice

Filed with the SEC on · accession 0001140361-26-044734

PASG filed a 8-K (current report) with the SEC on Nov 18, 2026. Passage Bio received a Nasdaq notice that it fails to meet the $2.5 million minimum stockholders' equity requirement, reporting only $50,000 in equity as of September 30, 2026.

Summary of the filing

Passage Bio received a Nasdaq notice that it fails to meet the $2.5 million minimum stockholders' equity requirement, reporting only $50,000 in equity as of September 30, 2026. The company expects to regain compliance upon completing its previously announced merger with Remix Therapeutics, after which it will rename itself Remix Therapeutics and trade under the symbol RMTX.

Key details

Minimum stockholders' equity required for Nasdaq Capital Market continued listing$2.5M
Reported stockholders' equity as of September 30, 2026$50K
RegistrantPassage Bio, Inc.
Listing exchange issuing deficiency noticeThe Nasdaq Stock Market LLC
Merger counterpartyRemix Therapeutics, Inc.
Wholly owned merger subsidiaryPeregrine Merger Sub, Inc.
Wholly owned merger subsidiaryPeregrine Merger Sub II, LLC
Chief financial officerKathleen Borthwick

✦ Ask GOAX AI about this filing — what it means for PASG, what changed since its last filings and what to watch next.

Try it free for 7 days

🔔 Want to stay updated on new SEC filings for PASG?

Click here

Frequently asked questions

What did PASG file with the SEC on Nov 18, 2026?

PASG filed a 8-K (Delisting notice). Passage Bio received a Nasdaq notice that it fails to meet the $2.5 million minimum stockholders' equity requirement, reporting only $50,000 in equity as of September 30, 2026. The company expects to regain compliance upon completing its previously announced merger with Remix Therapeutics, after which it will rename itself Remix Therapeutics and trade under the symbol RMTX.

What does a delisting notice mean for PASG stock?

The stock often falls sharply. In a Chapter 11 reorganization existing shares are frequently cancelled or heavily diluted; in Chapter 7 the company is liquidated and shareholders are paid last, usually nothing.

How do I read a 8-K?

A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more. The "Item" number tells you the topic (e.g. 2.02 results, 5.02 executive change, 1.01 new agreement, 1.03 bankruptcy). Exhibits (99.1 press release) usually hold the details.

Why are SEC filings important?

Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 8-K (current report): A report of a major event, filed within four business days: results, deals, leadership changes, bankruptcy and more.

Other PASG SEC filings

Get alerts when PASG files with the SEC, plus live charts, key levels and news for 13,000+ stocks.

Try SEPT free for 7 days